HEADER RNA BINDING PROTEIN 12-MAY-11 3S01 TITLE CRYSTAL STRUCTURE OF A HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L TITLE 2 (HNRPL) FROM MUS MUSCULUS AT 2.15 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RRM 3 DOMAIN CONTAING RESIDUES 376-586; COMPND 5 SYNONYM: HNRNP L; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: BC027206, HNRNPL, HNRPL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS FERREDOXIN-LIKE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, RNA KEYWDS 3 BINDING PROTEIN, PARTNERSHIP FOR STEM CELL BIOLOGY, STEMCELL, KEYWDS 4 PARTNERSHIP FOR T-CELL BIOLOGY, TCELL EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),PARTNERSHIP FOR STEM CELL AUTHOR 2 BIOLOGY (STEMCELL),PARTNERSHIP FOR T-CELL BIOLOGY (TCELL) REVDAT 5 01-FEB-23 3S01 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3S01 1 REMARK REVDAT 3 21-OCT-15 3S01 1 AUTHOR JRNL REVDAT 2 10-AUG-11 3S01 1 ATOM DBREF REMARK VERSN REVDAT 1 29-JUN-11 3S01 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG), JRNL AUTH 2 PARTNERSHIP FOR STEM CELL BIOLOGY (STEMCELL), JRNL AUTH 3 PARTNERSHIP FOR T-CELL BIOLOGY (TCELL) JRNL TITL CRYSTAL STRUCTURE OF A HETEROGENEOUS NUCLEAR JRNL TITL 2 RIBONUCLEOPROTEIN L (HNRPL) FROM MUS MUSCULUS AT 2.15 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11283 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 534 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2668 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1810 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2526 REMARK 3 BIN R VALUE (WORKING SET) : 0.1771 REMARK 3 BIN FREE R VALUE : 0.2478 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1616 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.37140 REMARK 3 B22 (A**2) : 3.21020 REMARK 3 B33 (A**2) : 2.16120 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.59450 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1684 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2274 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 776 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 44 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 248 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1684 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 209 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2000 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.53 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.65 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|0 - A|586 } REMARK 3 ORIGIN FOR THE GROUP (A): -7.8905 12.0963 13.1495 REMARK 3 T TENSOR REMARK 3 T11: -0.0453 T22: -0.0579 REMARK 3 T33: -0.0703 T12: -0.0086 REMARK 3 T13: 0.0133 T23: 0.0045 REMARK 3 L TENSOR REMARK 3 L11: 1.2298 L22: 1.1848 REMARK 3 L33: 1.1019 L12: -0.2601 REMARK 3 L13: -0.1619 L23: 0.2012 REMARK 3 S TENSOR REMARK 3 S11: -0.0338 S12: 0.0594 S13: 0.0116 REMARK 3 S21: -0.0632 S22: -0.0019 S23: -0.0371 REMARK 3 S31: -0.0606 S32: -0.0740 S33: 0.0358 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. WATERS WERE EXCLUDED FROM AUTOMATIC TLS ASSIGNMENT. REMARK 3 4. 2-PROPANOL (IPA) AND GLYCEROL (GOL) MOLECULES FROM THE REMARK 3 CRYSTALLIZATION/CRYOPROTECTION SOLUTIONS ARE MODELED. 5. THE MAD REMARK 3 PHASES (HL COEFFICIENTS) WERE USED AS RESTRAINTS DURING REMARK 3 REFINEMENT. REMARK 4 REMARK 4 3S01 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065589. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91162,0.97938 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE DECEMBER 6, 2010 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11314 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 29.512 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10.00% 2-PROPANOL, 20.00% POLYETHYLENE REMARK 280 GLYCOL 4000, 0.1M HEPES PH 7.5, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 18.98200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS AND ANALYTICAL SIZE EXCLUSION REMARK 300 CHROMATOGRAPHY SUPPORT THE ASSIGNMENT OF A MONOMER AS A SIGNIFICANT REMARK 300 OLIGOMERIZATION STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 535 REMARK 465 SER A 536 REMARK 465 GLU A 537 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 377 CG OD1 OD2 REMARK 470 LYS A 415 CD CE NZ REMARK 470 GLN A 460 CG CD OE1 NE2 REMARK 470 LEU A 507 CG CD1 CD2 REMARK 470 GLU A 512 CD OE1 OE2 REMARK 470 ARG A 538 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 504 30.49 70.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 421317 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 376-586 OF THE TARGET REMARK 999 SEQUENCE. NUMBERING IS BASED ON THE UNIPROTKB Q8R081 VERSION 2 REMARK 999 SEQUENCE. DBREF 3S01 A 376 586 UNP Q8R081 HNRPL_MOUSE 376 586 SEQADV 3S01 GLY A 0 UNP Q8R081 EXPRESSION TAG SEQRES 1 A 212 GLY ALA ASP SER PRO VAL LEU MSE VAL TYR GLY LEU ASP SEQRES 2 A 212 GLN SER LYS MSE ASN CYS ASP ARG VAL PHE ASN VAL PHE SEQRES 3 A 212 CYS LEU TYR GLY ASN VAL GLU LYS VAL LYS PHE MSE LYS SEQRES 4 A 212 SER LYS PRO GLY ALA ALA MSE VAL GLU MSE ALA ASP GLY SEQRES 5 A 212 TYR ALA VAL ASP ARG ALA ILE THR HIS LEU ASN ASN ASN SEQRES 6 A 212 PHE MSE PHE GLY GLN LYS MSE ASN VAL CYS VAL SER LYS SEQRES 7 A 212 GLN PRO ALA ILE MSE PRO GLY GLN SER TYR GLY LEU GLU SEQRES 8 A 212 ASP GLY SER CYS SER TYR LYS ASP PHE SER GLU SER ARG SEQRES 9 A 212 ASN ASN ARG PHE SER THR PRO GLU GLN ALA ALA LYS ASN SEQRES 10 A 212 ARG ILE GLN HIS PRO SER ASN VAL LEU HIS PHE PHE ASN SEQRES 11 A 212 ALA PRO LEU GLU VAL THR GLU GLU ASN PHE PHE GLU ILE SEQRES 12 A 212 CYS ASP GLU LEU GLY VAL LYS ARG PRO THR SER VAL LYS SEQRES 13 A 212 VAL PHE SER GLY LYS SER GLU ARG SER SER SER GLY LEU SEQRES 14 A 212 LEU GLU TRP ASP SER LYS SER ASP ALA LEU GLU THR LEU SEQRES 15 A 212 GLY PHE LEU ASN HIS TYR GLN MSE LYS ASN PRO ASN GLY SEQRES 16 A 212 PRO TYR PRO TYR THR LEU LYS LEU CYS PHE SER THR ALA SEQRES 17 A 212 GLN HIS ALA SER MODRES 3S01 MSE A 382 MET SELENOMETHIONINE MODRES 3S01 MSE A 391 MET SELENOMETHIONINE MODRES 3S01 MSE A 412 MET SELENOMETHIONINE MODRES 3S01 MSE A 420 MET SELENOMETHIONINE MODRES 3S01 MSE A 423 MET SELENOMETHIONINE MODRES 3S01 MSE A 441 MET SELENOMETHIONINE MODRES 3S01 MSE A 446 MET SELENOMETHIONINE MODRES 3S01 MSE A 457 MET SELENOMETHIONINE MODRES 3S01 MSE A 564 MET SELENOMETHIONINE HET MSE A 382 8 HET MSE A 391 8 HET MSE A 412 8 HET MSE A 420 8 HET MSE A 423 8 HET MSE A 441 8 HET MSE A 446 8 HET MSE A 457 8 HET MSE A 564 8 HET GOL A 600 6 HET IPA A 601 4 HET IPA A 602 4 HETNAM MSE SELENOMETHIONINE HETNAM GOL GLYCEROL HETNAM IPA ISOPROPYL ALCOHOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN IPA 2-PROPANOL FORMUL 1 MSE 9(C5 H11 N O2 SE) FORMUL 2 GOL C3 H8 O3 FORMUL 3 IPA 2(C3 H8 O) FORMUL 5 HOH *126(H2 O) HELIX 1 1 ASN A 392 CYS A 401 1 10 HELIX 2 2 ASP A 425 ASN A 437 1 13 HELIX 3 3 THR A 484 LYS A 490 1 7 HELIX 4 4 THR A 510 GLY A 522 1 13 HELIX 5 5 SER A 548 ASN A 560 1 13 SHEET 1 A 5 ASN A 447 VAL A 450 0 SHEET 2 A 5 VAL A 380 TYR A 384 -1 N MSE A 382 O CYS A 449 SHEET 3 A 5 ALA A 419 MSE A 423 -1 O VAL A 421 N LEU A 381 SHEET 4 A 5 VAL A 406 PHE A 411 -1 N GLU A 407 O GLU A 422 SHEET 5 A 5 TYR A 471 ASP A 473 -1 O LYS A 472 N VAL A 409 SHEET 1 B 2 PHE A 440 MSE A 441 0 SHEET 2 B 2 GLN A 444 LYS A 445 -1 O GLN A 444 N MSE A 441 SHEET 1 C 4 SER A 528 VAL A 531 0 SHEET 2 C 4 SER A 540 GLU A 545 -1 O LEU A 543 N LYS A 530 SHEET 3 C 4 VAL A 499 ALA A 505 -1 N LEU A 500 O LEU A 544 SHEET 4 C 4 LYS A 576 PHE A 579 -1 O CYS A 578 N HIS A 501 SHEET 1 D 2 GLN A 563 MSE A 564 0 SHEET 2 D 2 TYR A 573 THR A 574 -1 O TYR A 573 N MSE A 564 LINK C LEU A 381 N MSE A 382 1555 1555 1.31 LINK C MSE A 382 N VAL A 383 1555 1555 1.33 LINK C LYS A 390 N MSE A 391 1555 1555 1.32 LINK C MSE A 391 N ASN A 392 1555 1555 1.34 LINK C PHE A 411 N MSE A 412 1555 1555 1.34 LINK C MSE A 412 N LYS A 413 1555 1555 1.34 LINK C ALA A 419 N MSE A 420 1555 1555 1.35 LINK C MSE A 420 N VAL A 421 1555 1555 1.35 LINK C GLU A 422 N MSE A 423 1555 1555 1.34 LINK C MSE A 423 N ALA A 424 1555 1555 1.34 LINK C PHE A 440 N MSE A 441 1555 1555 1.32 LINK C MSE A 441 N PHE A 442 1555 1555 1.35 LINK C LYS A 445 N MSE A 446 1555 1555 1.34 LINK C MSE A 446 N ASN A 447 1555 1555 1.31 LINK C ILE A 456 N MSE A 457 1555 1555 1.35 LINK C MSE A 457 N PRO A 458 1555 1555 1.37 LINK C GLN A 563 N MSE A 564 1555 1555 1.34 LINK C MSE A 564 N LYS A 565 1555 1555 1.33 SITE 1 AC1 5 ASN A 398 SER A 477 ASN A 479 HIS A 561 SITE 2 AC1 5 HOH A 719 SITE 1 AC2 4 ASP A 547 SER A 548 LYS A 549 HOH A 629 SITE 1 AC3 3 TYR A 384 SER A 451 LYS A 452 CRYST1 48.672 37.964 57.953 90.00 105.44 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020546 0.000000 0.005675 0.00000 SCALE2 0.000000 0.026341 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017901 0.00000